Home

Features

  • FDA Scorecard: Drug Shortages and Inspections
    By

    How has the FDA performed in mitigating drug shortages and in its inspection activity since the COVID-19 pandemic? Has it been able to keep drug shortages down and keep pace with its inspection activity on levels on par pre-pandemic? Two recent reports tell the story.


  • Innovation in the Supply Chain: Building Resiliency
    By

    Having resilient supply chains is always of great importance, but even more so as customers and suppliers have had to adjust to new challenges in the wake of the pandemic. What are some innovative practices that companies are applying to their supply chain?


DCAT MEMBER COMPANY COMMUNITY